期刊
NATURE REVIEWS GENETICS
卷 14, 期 4, 页码 295-300出版社
NATURE PORTFOLIO
DOI: 10.1038/nrg3463
关键词
-
资金
- US National Institutes of Health [U41HG006834, U01HG006500]
With the declining cost of sequencing and the ongoing discovery of disease genes, it is now possible to examine hundreds of genes in a single disease-targeted test. Although exome- and genome-sequencing approaches are beginning to compete, disease-targeted testing retains certain advantages and still holds a firm place in the diagnostic evaluation. Here I examine the current state of clinical disease-targeted sequencing and evaluate the benefits and challenges of incorporating sequencing tests into patient care.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据